Trials / Conditions / Stage III Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
Stage III Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
5 registered clinical trials studyying Stage III Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers NCT05691504 | National Cancer Institute (NCI) | Phase 1 |
| Recruiting | Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Soli NCT05269381 | Mayo Clinic | Phase 1 / Phase 2 |
| Recruiting | Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tu NCT04704661 | National Cancer Institute (NCI) | Phase 1 |
| Active Not Recruiting | Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel a NCT03914612 | National Cancer Institute (NCI) | Phase 3 |
| Active Not Recruiting | Cabozantinib S-malate and Nivolumab in Treating Patients With Advanced, Recurrent, or Metastatic Endometrial C NCT03367741 | National Cancer Institute (NCI) | Phase 2 |